patent/BR-0208947-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0208947-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_251b882365ccac8fc662fe04de0707b3
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
filingDate	2002-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6064121f78c209175e573c08c7ea4d30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a31d2adc8878d81f9ab2620c84b0e6e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fa093fe5125c9ec9fee006b7905a7a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_841e045e6c809178fd147a65eb473f99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a25f401605ad5ce85d63b00d4a81fb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f72597be23290c94e2dad68036f2f661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_110bc52ca9c6b7d4e278d69188ad0f36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_753c6b31e4c56e56f5b47d5ce9db4676 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc09b700684cbb041cdaa12594221b85
publicationDate	2004-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	BR-0208947-A
titleOfInvention	Stabilized oral pharmaceutical composition
abstract	"STABILIZED ORAL PHARMACEUTICAL COMPOSITION". The invention relates to an orally distributable pharmaceutical composition provided comprising a drug comprising aminosulfonyl, for example a selective cyclooxygenase-2 inhibitory drug and a solvent liquid comprising a polyethylene glycol and one or more antioxidants for free radical removal. At least a substantial part of the drug is in dissolved form in the solvent liquid. The composition has rapid onset properties and is useful in treating cyclooxygenase-2 mediated conditions and disorders.
priorityDate	2001-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457584123 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5743 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID442942

Total number of triples: 61.